Aratana Therapeutics Postpones $51 Million IPO

Published: Jun 19, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Aratana Therapeutics Inc.'s scheduled IPO didn't go as planned last week. The animal health company, based in Kansas City, Kan., did not list as had been initially speculated, and some reports have the company making a new attempt later this week. The company, led by CEO Steven St. Peter, initially sought to sell 4.25 million shares within the price range of $11 and $13 a share.

Help employers find you! Check out all the jobs and post your resume.

Back to news